M. Hilleman

发表

M. Hilleman, 1961, Science.

Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines.

M. Hilleman, P. Vella, A. J. Carlson, 1981, Reviews of infectious diseases.

Immunologic studies of measles.

M. Hilleman, J. Stokes, C. M. Reilly, 1961, American journal of hygiene.

Persistence of Antibody in Human Subjects for 7 to 10 Years following Administration of Combined Live Attenuated Measles, Mumps, and Rubella Virus Vaccines

M. Hilleman, A. Mclean, R. Weibel, 1980, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Double-Stranded Polynucleotides as Interferon Inducers

M. Hilleman, A. Field, A. Tytell, 1970, The Journal of general physiology.

Vaccinology, immunology, and comparative pathogenesis of measles in the quest for a preventative against AIDS.

M. Hilleman, 1994, AIDS research and human retroviruses.

Line cell saga - an argument in favor of production of biologics in cancer cells.

M. Hilleman, 1979, Advances in experimental medicine and biology.

Live attenuated mumps-virus vaccine. IV. Protective efficacy as measured in a field evaluation.

M. Hilleman, J. Whitman, R. Weibel, 1967, The New England journal of medicine.

Factors Influencing Tumor Induction in Hamsters by Vacuolating Virus, SV40.∗

M. Hilleman, A. Girardi, B. H. Sweet, 1963, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Development of Tumors in Hamsters Inoculated in the Neonatal Period with Vacuolating Virus, SV40 ∗

M. Hilleman, A. Girardi, B. H. Sweet, 1962, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Enhancement in hamsters of virus oncogenesis attending vaccination procedures.

M. Hilleman, A. Girardi, H. Goldner, 1965, Virology.

Personal historical chronicle of six decades of basic and applied research in virology, immunology, and vaccinology

M. Hilleman, 1999, Immunological reviews.

Overview: Past and future of immunologic intervention in the pathogenesis, prophylaxis and therapeusis of hepatitis B

M. Hilleman, 2002, Journal of Gastroenterology and Hepatology.

Three Decades of Hepatitis Vaccinology in Historic Perspective. A Paradigm of Successful Pursuits

M. Hilleman, 2011 .

The business of science and the science of business in the quest for an AIDS vaccine.

M. Hilleman, 1999, Vaccine.

Inducers of interferon and host resistance. I. Double-stranded RNA from extracts of Penicillium funiculosum.

M. Hilleman, A. Field, A. Tytell, 1967, Proceedings of the National Academy of Sciences of the United States of America.

Development and evaluation of the Moraten measles virus vaccine.

M. Hilleman, J. Whitman, R. Weibel, 1968, JAMA.

Live, attenuated mumps-virus vaccine.

M. Hilleman, R. Weibel, J. Stokes, 1968, The New England journal of medicine.

Double-Stranded RNA’s in Relation to Interferon Induction and Adjuvant Activity

M. Hilleman, I. Krakoff, C. Young, 1971 .

Double-stranded RNAs (poly I:C) in the prevention of viral infections.

M. Hilleman, 1970, Archives of internal medicine.

Toward control of viral infections of man.

M. Hilleman, 1969, Science.

INTERFERON IN PROSPECT AND PERSPECTIVE.

M. Hilleman, 1963, Journal of cellular and comparative physiology.

Vaccine against human hepatitis B.

M. Hilleman, E. Buynak, R. R. Roehm, 1976, JAMA.

Pneumococcal Vaccines

M. Hilleman, P. Vella, A. Mclean, 1978, The Lancet.

Antibody response in volunteers to Asian influenza vaccine.

D. Levinson, M. Hilleman, S. Anderson, 1958, Journal of the American Medical Association.

The preparation and safety of hepatitis B vaccine.

M. Hilleman, A. Mclean, E. Buynak, 1983, The Journal of infection.

Hepatitis and hepatitis A vaccine: a glimpse of history.

M. Hilleman, 1993, Journal of hepatology.

Overview of viruses, cancer, and vaccines in concept and in reality.

M. Hilleman, 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

The Development of Live Attenuated Mumps Virus Vaccine in Historic Perspective and Its Role in the Evolution of Combined Measles–Mumps–Rubella

M. Hilleman, 2011 .

Studies in Human Subjects of Polyvalent Pneumococcal Vaccines

M. Hilleman, P. Vella, A. Mclean, 1977, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Clinical and laboratory findings in cases of respiratory illness caused by coryzaviruses.

M. Hilleman, V. Hamparian, J. Stokes, 1962, Annals of internal medicine.

Clinical manifestations, according to age, among females given HPV-77 duck rubella vaccine.

M. Hilleman, N. Goldblum, T. Swartz, 1971, American journal of epidemiology.

Protective efficacy of pneumococcal polysaccharide vaccines.

M. Hilleman, H. Koornhof, S. Hayden-Smith, 1977, JAMA.

Vaccines in historic evolution and perspective: a narrative of vaccine discoveries.

M. Hilleman, 2000, Journal of human virology.

EPIDEMIOLOGY OF ADENOVIRUS RESPIRATORY INFECTIONS IN MILITARY RECRUIT POPULATIONS

M. Hilleman, 1957, Annals of the New York Academy of Sciences.

Inducers of interferon and host resistance, IV. Double-stranded replicative form RNA (MS2-Ff-RNA) from E. coli infected with MS2 coliphage.

M. Hilleman, A. Field, A. Tytell, 1967, Proceedings of the National Academy of Sciences of the United States of America.

Preparation and testing of duck embryo cell culture rubella vaccine.

M. Hilleman, E. Buynak, W. Mcaleer, 1969, American journal of diseases of children.

Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections

M. Hilleman, 2004, Proceedings of the National Academy of Sciences of the United States of America.

The Vacuolating Virus, S.V.40

M. Hilleman, B. H. Sweet, 1960, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Cooperation between government and industry in combating a perceived emerging pandemic. The 1976 swine influenza vaccination program.

M. Hilleman, 1996, JAMA.

Impediments, imponderables and alternatives in the attempt to develop an effective vaccine against AIDS.

M. Hilleman, 1992, Vaccine.

Pneumococcal Vaccine: Dose, Revaccination, and Coadministration with Influenza Vaccine

M. Hilleman, P. Vella, A. J. Carlson, 1979, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Persistence of Pneumococcal Antibodies in Human Subjects following Vaccination

M. Hilleman, P. Vella, A. Mclean, 1980, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Propagation of Human Hepatitis A Virus in Cell Culture in Vitro

M. Hilleman, P. Provost, 1979, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

IMMUNOLOGIC, CHEMOTHERAPEUTIC AND INTERFERON APPROACHES TO CONTROL OF VIRAL DISEASE.

M. Hilleman, 1965, The American journal of medicine.

Laboratory and field investigations of bovine Myxovirus parainfluenza 3 virus and vaccine. III. Evaluation of an SF-4 (shipping fever) virus vaccine in cattle.

M. Hilleman, V. Hamparian, A. Ketler, 1961, Journal of immunology.

Laboratory and field investigations of bovine Myxovirus parainfluenza 3 virus and vaccine. I. Properties of the SF-4 (shipping fever) strain of virus.

M. Hilleman, V. Hamparian, A. Ketler, 1961, Journal of immunology.

History, precedent, and progress in the development of mammalian cell culture systems for preparing vaccines: Safety considerations revisited

M. Hilleman, 1990, Journal of medical virology.

Long-term follow-up for immunity after monovalent or combined live measles, mumps, and rubella virus vaccines.

M. Hilleman, A. Mclean, R. Weibel, 1975, Pediatrics.

Characterization and Classification of ECHO 28-Rhinovirus-Coryzavirus Agents

M. Hilleman, V. Hamparian, A. Ketler, 1962, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Hepatitis B and AIDS and the promise for their control by vaccines.

M. Hilleman, 1988, Vaccine.

Overview of vaccinology with special reference to papillomavirus vaccines.

M. Hilleman, 2000, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Yeast recombinant hepatitis B vaccine

M. Hilleman, 2005, Infection.

Vaccines against hepatitis A and B

D. Nalin, M. Hilleman, J. Ryan, 1993 .

New Findings in Live, Attenuated Hepatitis A Vaccine Development

E. Scolnick, M. Hilleman, C. Stevens, 1986, Journal of medical virology.

Studies in Chimpanzees of Live, Attenuated Hepatitis A Vaccine Candidates

M. Hilleman, E. Buynak, W. Mcaleer, 1983, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Progress toward a Live, Attenuated Human Hepatitis A Vaccine

M. Hilleman, E. Buynak, W. Mcaleer, 1982, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Clinical and Laboratory Studies of Combined Live Measles, Mumps, and Rubella Vaccines Using the RA 27/3 Rubella Virus

M. Hilleman, A. Mclean, R. Weibel, 1980, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Stability on storage at various temperatures of live measles, mumps and rubella virus vaccines in new stabilizer.

M. Hilleman, H. Markus, A. Mclean, 1980, Journal of biological standardization.

Follow-Up Surveillance for Antibody in Human Subjects following Live Attenuated Measles, Mumps, and Rubella Virus Vaccines

M. Hilleman, A. Mclean, R. Weibel, 1979, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Physical, Chemical and Morphologic Dimensions of Human Hepatitis A Virus Strain CR326

M. Hilleman, W. Miller, W. Mcaleer, 1975 .

Combined live measles-mumps virus vaccine.

M. Hilleman, R. Weibel, J. Stokes, 1973, Archives of disease in childhood.

Combined live measles-rubella virus vaccine. Findings in clinical laboratory studies.

M. Hilleman, R. Weibel, J. Stokes, 1971, The Journal of pediatrics.

Jeryl Lynn Strain Live Attenuated Mumps Virus Vaccine: Influence of Age, Virus Dose, Lot, and γGlobulin Administration on Response

M. Hilleman, J. Whitman, R. Weibel, 1968 .

Comparison of Neutralization and Hemagglutination-Inhibition Techniques for Measuring Mumps Antibody

D. Morton, M. Hilleman, J. Whitman, 1967, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Haemophilus influenzae Type b Polysaccharide-Protein Conjugate Vaccine

M. Hilleman, J. Y. Tai, P. Vella, 1987, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Inactivation of hepatitis B virus by three methods: Treatment with pepsin, urea, or formalin

M. Hilleman, P. Snoy, E. Tabor, 1983, Journal of medical virology.

NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. 3. EFFICACY AND TOXICITY STUDIES IN MAN.

M. Hilleman, R. Weibel, A. Woodhour, 1964, The New England journal of medicine.

The Promise and the Reality of Viral Vaccines against Cancer

M. Hilleman, 1993, Annals of the New York Academy of Sciences.

Perspectives in Disease Prevention by Vaccines

M. Hilleman, 1987 .

Newer directions in vaccine development and utilization.

M. Hilleman, Maurice R. Hilleman, 1985, The Journal of infectious diseases.

Immunologic Prevention of Human Hepatitis

M. Hilleman, 2015, Perspectives in biology and medicine.

Whither immunization against viral infections?

M. Hilleman, 1984, Annals of internal medicine.

Specific Immune Adherence Assay for Human Hepatitis A Antibody. Application to Diagnostic and Epidemiologic Investigations

M. Hilleman, W. Miller, W. Mcaleer, 1975, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

A Specific Complement-Fixation Test for Human Hepatitis A Employing CR326 Virus Antigen. Diagnosis and Epidemiology

M. Hilleman, P. Provost, V. Villarejos, 1975, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Electron microscopy of type 4 adenovirus strain R1-67.

M. Hilleman, A. Tousimis, 1957, Virology.

Influence of age on clinical response to HPV-77 duck rubella vaccine.

M. Hilleman, R. Weibel, J. Stokes, 1972, JAMA.

Purified and inactivated human hepatitis B vaccine: progress report.

M. Hilleman, E. Buynak, R. R. Roehm, 1975, The American journal of the medical sciences.

Trivalent combined measles-mumps-rubella vaccine. Findings in clinical-laboratory studies.

M. Hilleman, R. Weibel, J. Stokes, 1971, JAMA.

Antigenicity of Double-Stranded Ribonucleic Acids Including Poly I:C

M. Hilleman, A. Field, A. Tytell, 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Combined Measles, Mumps, and Rubella Vaccines

M. Hilleman, 1999 .

Therapeutic vaccines: Realities of today and hopes for tomorrow

M. Hilleman, M. Sela, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Critical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus.

M. Hilleman, 2003, Vaccine.

Overview: cause and prevention in biowarfare and bioterrorism.

M. Hilleman, Maurice R Hilleman, 2002, Vaccine.

Vaccines in historic evolution and perspective: a narrative of vaccine discoveries.

M. Hilleman, 2000, Vaccine.

International biological standardization in historic and contemporary perspective.

M. Hilleman, 1999, Developments in biological standardization.

Six decades of vaccine development—a personal history

M. Hilleman, 1998, Nature Medicine.

Vaccines, human experimentation, and ethics in evolutionary perspective.

M. Hilleman, 1998, Developments in biological standardization.

Improving the heat stability of vaccines: problems, needs, and approaches.

M. Hilleman, 1989, Reviews of infectious diseases.

System for Measuring and Designating Antigenic Components of Influenza Viruses with Analyses of Recently Isolated Strains

M. Hilleman, 1951, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Antigenic Pattern of Strains of Influenza A and B

R. Mason, M. Hilleman, E. Buescher, 1950, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Laboratory studies on the 1950 outbreak of influenza.

R. Mason, M. Hilleman, N. Rogers, 1950, Public health reports.

Immunologic Relations of the Psittacosis-Lymphogranuloma Group of Viral Agents.∗

M. Hilleman, F. B. Gordon, 1944 .

Recovery of Hepatitis Agents in the Marmoset from Human Cases Occurring in Costa Rica

M. Hilleman, P. Provost, C. Mascoli, 1973, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes.

M. Hilleman, A. Field, A. Tytell, 1967, Proceedings of the National Academy of Sciences of the United States of America.

Problems and potentials for human viral cancer vaccines.

M. Hilleman, 1972, Preventive medicine.

Marek's disease vaccine: its implications in biology and medicine.

M. Hilleman, 1972, Avian diseases.

Overview of Vaccinology in Historic and Future Perspective

M. Hilleman, 2003 .

Contributions to Characterization and Classification of Animal Viruses

M. Hilleman, V. Hamparian, A. Ketler, 1963, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

CHAPTER 19 – Prospects for Vaccines against Cancer

M. Hilleman, 1974 .

Interruption of SV40 Virus Tumorigenesis Using Irradiated Homologous Tumor Antigen.∗

M. Hilleman, A. Girardi, H. Goldner, 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Studies on lymphogranuloma venereum complement-fixing antigens; enhancement by phenol or boiling.

M. Hilleman, C. Nigg, B. M. Bowser, 1946, Journal of immunology.

ADENOVIRUS (RI-APC-ARD) VACCINE FOR PREVENTION OF ACUTE RESPIRATORY ILLNESS: 2. FIELD EVALUATION

M. Hilleman, S. Anderson, R. Stallones, 1957 .

Adenovirus (RI-APC-ARD) vaccine for prevention of acute respiratory illness. I. Vaccine development.

M. Hilleman, S. Anderson, J. Werner, 1957, Journal of the American Medical Association.

Clinical and Laboratory Studies of Live Cytomegalovirus Vaccine Ad-169

M. Hilleman, A. Mclean, R. Weibel, 1979, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Human hepatitis B vaccine from recombinant yeast

M. Hilleman, W. Miller, E. Buynak, 1984, Nature.

Immunologic Attack on Neoplasia

M. Hilleman, 1966 .

Persistence of immunity following monovalent and combined live measles, mumps, and rubella virus vaccines.

M. Hilleman, R. Weibel, J. Stokes, 1973, Pediatrics.

Hyperpotentiation by Synthetic Double-Stranded RNA of Antibody Responses to Influenza Virus Vaccine in Adjuvant 65

M. Hilleman, A. Friedman, A. Woodhour, 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Inducers of interferon and host resistance, V. In vitro studies.

M. Hilleman, A. Field, A. Tytell, 1968, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of Chick Embryo Interferon Induced by a DNA Virus

M. Hilleman, A. Tytell, G. Lampson, 1965, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Effective Treatment of Experimental Herpes Simplex Keratitis with New Derivative, 5-Methylamino-2′-Deoxyuridine (MADU)

M. Hilleman, M. M. Nemes, 1965, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Antibody response in volunteers to adenovirus vaccine and correlation of antibody with immunity.

D. Levinson, M. Hilleman, S. Anderson, 1958, Journal of immunology.

Perspectives for testing safety of live measles vaccine.

M. Hilleman, H. Goldner, 1962, American journal of diseases of children.

Optimization techniques: Studies in cell culture

M. Hilleman, J. Schwartz, W. Mcaleer, 1983 .

New Metabolizable Immunologic Adjuvant∗ for Human Use. 2. Short-term Animal Toxicity Tests

M. Hilleman, A. Woodhour, D. Metzgar, 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Tests for Oncogenicity of Viruses Under Conditions of Altered Host and Virus 1

M. Hilleman, W. Clark, P. Conard, 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Host-Virus Relationships in Hamsters Inoculated with SV40 Virus During the Neonatal Period.∗

M. Hilleman, A. Girardi, 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Measurement of immunity following live mumps (5 years), measles (3 years), and rubella (2 and one-half years) virus vaccines.

M. Hilleman, R. Weibel, J. Stokes, 1972, Pediatrics.

Inducers of interferon and host resistance. 3. Double-stranded RNA from reovirus type 3 virions (reo 3-RNA).

M. Hilleman, A. Field, A. Tytell, 1967, Proceedings of the National Academy of Sciences of the United States of America.

Relationship of Molecular Size of rIn:rCn (Poly I:C) to Induction of Interferon and Host Resistance

M. Hilleman, A. Field, A. Tytell, 1970, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Use of living attenuated measles-virus vaccine in early infancy.

M. Hilleman, J. Stokes, C. M. Reilly, 1960, The New England journal of medicine.

A tribute to Dr. Friedrich W. Deinhardt M.D. 1926-1992.

M. Hilleman, 1993, Journal of hepatology.

Fritz will be remembered, for he was a servant to mankind and the world is a better place, because he was here. On this last fallen leaf, we inscribe our final tribute to Fritz, 'Farewell, good Friend; well done!'

M. Hilleman, 1992 .

Hepatitis viruses and vaccines

M. Hilleman, A. Mclean, W. Miller, 1978 .

Infectious hepatitis (hepatitis A) research in nonhuman primates.

M. Hilleman, W. Miller, E. Buynak, 1977, Bulletin of the Pan American Health Organization.

Evidence for viral hepatitis other than type A or type B among persons in Costa Rica.

M. Hilleman, K. Visoná, P. Provost, 1975, The New England journal of medicine.

Viruses of special interest to the dermatologist; a review.

M. Hilleman, 1950, Archives of dermatology and syphilology.

Influence of non-specific inhibitor on the diagnostic hemagglutination-inhibition test for influenza.

M. Hilleman, J. Werner, 1953, Journal of immunology.

Studies of acute respiratory illnesses caused by respiratory syncytial virus. 2. Epidemiology and assessment of importance.

M. Hilleman, V. Hamparian, J. Stokes, 1961, The New England journal of medicine.

Influenza antibodies in the population of the USA; an epidemiological investigation.

M. Hilleman, R. Gauld, J. Werner, 1953, Bulletin of the World Health Organization.

Purification and Characterization of Chick Embryo Interferon

M. Hilleman, A. Tytell, G. Lampson, 1963, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Comparative biology and pathogenesis of AIDS and hepatitis B viruses: related but different.

M. Hilleman, 1994, AIDS research and human retroviruses.

Human cancer virus vaccines and the pursuit of the practical

M. Hilleman, 1974, Cancer.

Tests in Hamsters for Oncogenic Quality of Ordinary Viruses Including Adenovirus Type 7.∗

M. Hilleman, A. Girardi, R. E. Zwickey, 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Live Attenuated Mumps Virus Vaccine. 1. Vaccine Development

M. Hilleman, E. Buynak, 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

THE PARAINFLUENZA VIRUSES OF MAN

M. Hilleman, 1962, Annals of the New York Academy of Sciences.

Interferon induction and utilization

M. Hilleman, 1968, Journal of cellular physiology.

The Newer Live Virus Vaccines

M. Hilleman, 2009 .

Persistence of immunity four years following Jeryl Lynn strain live mumps virus vaccine.

M. Hilleman, R. Weibel, J. Stokes, 1970, Pediatrics.

Vaccination of adults with live attenuated mumps virus vaccine.

M. Hilleman, J. Whitman, E. Buynak, 1967, JAMA.

Pathogenicity and oncolytic capacity of RI virus strain RI-67 in man.

M. Hilleman, C. Southam, J. Werner, 1956, The Journal of laboratory and clinical medicine.

Overview of the pathogenesis, prophylaxis and therapeusis of viral hepatitis B, with focus on reduction to practical applications.

M. Hilleman, 2001, Vaccine.

Live attenuated varicella virus vaccine. Efficacy trial in healthy children.

E. Scolnick, M. Hilleman, H. Guess, 1984, The New England journal of medicine.

Quality and safety of human hepatitis B vaccine.

M. Hilleman, A. Mclean, E. Buynak, 1983, Developments in biological standardization.

Influence of Size of Individual Homopolynucleotides on the Physical and Biological Properties of Complexed rIn:rCn (Poly I:C)

M. Hilleman, A. Field, A. Tytell, 1970, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Efficacy of and indications for use of adenovirus vaccine.

M. Hilleman, 1958, American journal of public health and the nation's health.

Antigenic relationships among adenoviruses with appraisal of reliability of complement-fixation test for typing isolates.

M. Hilleman, L. Binn, J. E. Rodriguez, 1958, Journal of Immunology.

Biophysical Characterization of the RI (RI-67) Viruses.∗

M. Hilleman, A. Tousimis, J. Werner, 1955, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Adenovirus vaccine; development, field evaluation, and appraisal of the need for vaccination in military and civilian populations.

M. Hilleman, 1958, A.M.A. archives of internal medicine.

Adenoviruses: group name proposed for new respiratory-tract viruses.

M. Hilleman, R. Huebner, T. Francis, 1956, Science.

A guinea pig potency test for adenovirus vaccine.

M. Hilleman, L. Binn, 1960, Journal of immunology.

Appraisal of occurrence of adenovirus-caused respiratory illness in military populations.

M. Hilleman, S. Anderson, R. Stallones, 1957, American journal of hygiene.

Clinical and laboratory studies in patients with respiratory disease caused by adenoviruses (RI-APC-ARD agents).

M. Hilleman, H. E. Dascomb, 1956, The American journal of medicine.

Prevention of Acute Respiratory Illness in Recruits by Adenovirus∗ (RI-APC-ARD) Vaccine.†

M. Hilleman, S. Anderson, R. Stallones, 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Grouping and Occurrence of RI (Prototype RI-67) Viruses.∗

M. Hilleman, M. T. Stewart, J. Werner, 1955, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Epidemiology of RI(RI-67) group respiratory virus infections in recruit populations.

M. Hilleman, H. E. Dascomb, M. T. Stewart, 1955, American journal of hygiene.

Epidemiologic investigations with respiratory disease virus RI-67.

M. Hilleman, H. E. Dascomb, J. Werner, 1955, American journal of public health and the nation's health.

Prospects for the use of double-stranded ribonucleic acid (poly I:C) inducers in man.

M. Hilleman, 1970, The Journal of infectious diseases.

Clinical and Laboratory Studies of KMcC Strain Live Attenuated Varicella Virus

M. Hilleman, A. Mclean, R. Weibel, 1981, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Vaccination and Revaccination with Polyvalent Pneumococcal Polysaccharide Vaccines in Adults and Infants

M. Hilleman, P. Vella, A. Mclean, 1978, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Chemotherapy in bubonic lymphogranuloma venereum: a clinical and serological evaluation.

A. B. Greaves, M. Hilleman, M. Feld, 1957, Bulletin of the World Health Organization.

POLY I:C, AN INDUCER OF INTERFERON AND INTERFERENCE AGAINST VIRUS INFECTIONS

M. Hilleman, E. Piperno, A. Field, 1972, Medicine.

The Effect of Altering the Size of Poly C on the Toxicity and Antigenicity of Poly I:C

M. Hilleman, A. Field, A. Tytell, 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

A simplified vaccinologists' vaccinology and the pursuit of a vaccine against AIDS.

M. Hilleman, 1998, Vaccine.

Overview: practical insights from comparative immunology and pathogenesis of AIDS, hepatitis B, and measles for developing an HIV vaccine.

M. Hilleman, 1995, Vaccine.

Summary of worldwide clinical experience with H-B-Vax (B, MSD).

M. Hilleman, A. Mclean, E. Buynak, 1983, The Journal of infection.

Further Investigations of Live Respiratory Syncytial Virus Vaccine Administered Parenterally

M. Hilleman, A. Mclean, R. Weibel, 1979, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Studies of acute respiratory illnesses caused by respiratory syncytial virus. 3. Clinical and laboratory findings.

M. Hilleman, V. Hamparian, J. Stokes, 1961, The New England journal of medicine.

Vaccines made from recombinant yeast cells.

M. Hilleman, R. Ellis, 1986, Vaccine.

Vaccination against acute respiratory illness of adenovirus (RI-APC-ARD) etiology.

M. Hilleman, S. Anderson, R. Stallones, 1957, American journal of public health and the nation's health.

Suitability of the Rufiventer Marmoset as a Host Animal for Human Hepatitis A Virus

M. Hilleman, P. Provost, V. Villarejos, 1977, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Etiologic Relationship of Marmoset-Propagated CR326 Hepatitis A Virus to Hepatitis in Man

M. Hilleman, P. Provost, V. Villarejos, 1973, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Acute respiratory illness in volunteers following intramuscular administration of live adenovirus.

M. Hilleman, S. Anderson, R. Hodges, 1957, The Journal of clinical investigation.

OUTBREAK OF ACUTE RESPIRATORY ILLNESS CAUSED BY RI-67 AND INFLUENZA A VIRUSES, FORT LEONARD WOOD, 1952–1953,

M. Hilleman, C. Adair, J. Werner, 1955 .

Second field evaluation of bivalent Types 4 and 7 adenovirus vaccine.

M. Hilleman, S. Anderson, J. Greenberg, 1958, A.M.A. archives of internal medicine.

POLIOVIRUS VACCINES IN MINERAL OIL ADJUVANT. I. ANIMAL TOXICITY AND SEROLOGIC RESPONSE DATA.

M. Hilleman, B. H. Sweet, B. Hampil, 1963, The Journal of allergy.

POLIOVIRUS VACCINES IN MINERAL OIL ADJUVANT. II. CLINICAL REACTION AND ANTIBODY RESPONSE.

M. Hilleman, S. Krugman, A. Tytell, 1963, The Journal of allergy.

Complement-Fixation Reaction of Human Neoplastic Tissue with Sera From Hamsters Bearing Virus-Induced Tumors.∗

M. Hilleman, V. Larson, P. Gosnell, 1967, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Studies of Oncogenicity of Adenovirus Type 7 Viruses in Hamsters.∗

M. Hilleman, A. Girardi, R. E. Zwickey, 1965, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Advances in control of viral infections by nonspecific measures and by vaccines, with special reference to live mumps and rubella virus vaccines

M. Hilleman, 1966, Clinical pharmacology and therapeutics.

DNA Vectors Precedents and Safety

M. Hilleman, M R Hilleman, 1995, Annals of the New York Academy of Sciences.

THE ECHO 28-RHINOVIRUS-CORYZAVIRUS (ERC) GROUP OF VIRUSES.

M. Hilleman, V. Hamparian, A. Ketler, 1963, The American review of respiratory disease.

ECHO virus, type 25, in respiratory illness. Case report.

M. Hilleman, V. Hamparian, J. Stokes, 1963, The Journal of pediatrics.

Acute respiratory illnesses among children and adults. Field study of contemporary importance of several viruses and appraisal of the literature.

M. Hilleman, V. Hamparian, J. Stokes, 1962, JAMA.

Recovery of New Viruses (Coryzavirus) from Cases of Common Cold in Human Adults

M. Hilleman, V. Hamparian, A. Ketler, 1961, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Studies of Acute Respiratory Illnesses Caused by Respiratory Syncytial Virus. 1. Laboratory Findings in 109 Cases

M. Hilleman, V. Hamparian, J. Stokes, 1961, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

CLINICAL-EPIDEMIOLOGIC FINDINGS IN CORYZAVIRUS INFECTIONS.

M. Hilleman, V. Hamparian, J. Stokes, 1963, The American review of respiratory disease.

Additional Rhinovirus Serotypes

M. Hilleman, V. Hamparian, M. B. Leagus, 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Epidemiologic Investigations of Rhinovirus Infections

M. Hilleman, J. Stokes, M. B. Leagus, 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Live attenuated rubella virus vaccines prepared in duck embryo cell culture. I. Development and clinical testing.

M. Hilleman, R. Weibel, J. Stokes, 1968, JAMA.

Attempt at Immunization by Oral Feeding of Live Rhinoviruses in Enteric-Coated Capsules

M. Hilleman, R. Weibel, J. Stokes, 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Rhinovirus Infection in Nursery and Kindergarten Children. New Rhinovirus Serotype 54

M. Hilleman, R. Weibel, J. Stokes, 1967, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Enzyme-linked immunosorbent assay for measurement of antibodies against pneumococcal polysaccharide antigens: comparison with radioimmunoassay

M. Hilleman, A. Woodhour, J. Meeker, 1979, Journal of clinical microbiology.

Antigenic variation of influenza viruses.

M. Hilleman, 1954, Annual review of microbiology.

Search for Virus in Human Malignancies. 1. In vitro Studies.∗

M. Hilleman, A. Girardi, V. Slotnick, 1962, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Jeryl Lynn strain live attenuated mumps virus vaccine. Durability of immunity following administration.

M. Hilleman, R. Weibel, J. Stokes, 1968, JAMA.

Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control.

M. Hilleman, Maurice R Hilleman, 2002, Vaccine.

Live attenuated mumps-virus vaccine. 3. Clinical and serologic aspects in a field evaluation.

M. Hilleman, J. Whitman, R. Weibel, 1967, The New England journal of medicine.

Distribution and significance of Asian and other influenza antibodies in the human population.

D. Levinson, M. Hilleman, S. Anderson, 1958, The New England journal of medicine.

Polyvalent pneumococcal polysaccharide vaccines.

M. Hilleman, P. Vella, A. Mclean, 1979, Bulletin of the World Health Organization.

DNA vaccines : a new era in vaccinology

M. Hilleman, R. Kurth, Margaret A. Liu, 1995 .

Jeryl Lynn strain live mumps virus vaccine. Durable immunity for three years following vaccination.

M. Hilleman, J. Whitman, R. Weibel, 1969, JAMA.

Experiences with Jeryl Lynn strain live attenuated mumps virus vaccine in a pediatric outpatient clinic.

M. Hilleman, M. Young, R. Weibel, 1967, Pediatrics.

Live rubella vaccines in adults and children. HPV-77 and Merck-Benoit strains.

M. Hilleman, R. Weibel, J. Stokes, 1969, American journal of diseases of children.

Administration of Enders' live measles virus vaccine with human immune globulin.

M. Hilleman, R. Weibel, J. Stokes, 1962, JAMA.

Ender's live measles-virus vaccine with human immune globulin. II. Evaluation of efficacy.

M. Hilleman, J. Stokes, E. Buynak, 1962, American journal of diseases of children.

Enders' live measles-virus vaccine with human immune globulin. I. Clinical reactions.

M. Hilleman, J. Stokes, C. M. Reilly, 1962, American journal of diseases of children.

Living attenuated measles-virus vaccine in early infancy. Studies of the role of passive antibody in immunization.

M. Hilleman, J. Stokes, C. M. Reilly, 1961, The New England journal of medicine.

The control of viral diseases, with special reference to mumps, rubella, and interferon

M. Hilleman, 1968, Clinical pharmacology and therapeutics.

Efficacy of Live, Attenuated Measles-Virus Vaccine given with Human Immune Globulin. A Preliminary Report.

M. Hilleman, R. Weibel, J. Stokes, 1961 .

Combined live measles, mumps, and rubella virus vaccines.

M. Hilleman, J. Whitman, R. Weibel, 1969, JAMA.

DURABLE IMMUNITY TWO YEARS AFTER ADMINISTRATION OF ENDERS'S LIVE MEASLES-VIRUS VACCINE WITH IMMUNE GLOBULIN.

M. Hilleman, R. Weibel, J. Stokes, 1964, The New England journal of medicine.

Persistent immunity following Enders live, attenuated measles-virus vaccine given with human immune globulin.

M. Hilleman, R. Weibel, J. Stokes, 1962, The New England journal of medicine.

Immunogenic response to killed measles-virus vaccine. Studies in animals and evaluation of vaccine efficacy in an epidemic.

M. Hilleman, J. Stokes, C. M. Reilly, 1962, American journal of diseases of children.

Studies of live attenuated measles virus vaccine in man. II. Appraisal of efficacy.

M. Hilleman, J. Stokes, E. Buynak, 1962, American journal of public health and the nation's health.

Studies of live attenuated measles virus vaccine in man. I. Clinical aspects.

M. Hilleman, J. Stokes, C. M. Reilly, 1962, American journal of public health and the nation's health.

Titration of Chick Embryo Cell Culture Measles Vaccine in Children

M. Hilleman, C. M. Reilly, E. Buynak, 2016 .

Infectivity stability of live measles-virus vaccine.

M. Hilleman, E. Buynak, H. Goldner, 1962, American journal of diseases of children.

Combined live rubella-mumps virus vaccine. Findings in clinical-laboratory studies.

M. Hilleman, R. Weibel, J. Stokes, 1971, JAMA.

Rubella vaccination in adult females.

M. Hilleman, R. Weibel, J. Stokes, 1969, The New England journal of medicine.

Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines.

M. Hilleman, A. Mclean, R. Weibel, 1978, Pediatrics.

Live attenuated rubella virus vaccines. Experiences with duck embryo cell preparations.

M. Hilleman, J. Whitman, J. Stokes, 1969, American journal of diseases of children.

Rubella virus vaccine (HPV-77-DE 5). Antigenic and protective efficacy in a community trial.

M. Hilleman, R. W. Mccollum, E. Byrne, 1969, American journal of diseases of children.

Rubella Vaccination in Adult Females

M. Hilleman, R. Weibel, J. Stokes, 1969 .

Live attenuated rubella virus vaccines prepared in duck embryo cell culture. II. Clinical tests in families and in an institution.

M. Hilleman, J. Whitman, R. Weibel, 1968, JAMA.

Live, attenuated rubella-virus vaccine.

M. Hilleman, R. Weibel, J. Stokes, 1968, The New England journal of medicine.

The Frustrating Journey toward an AIDS Vaccine

M. Hilleman, 2000 .

Induction of Interferon in Human Subjects by Poly I:C

M. Hilleman, I. Krakoff, C. Young, 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Current overview of the pathogenesis and prophylaxis of measles with focus on practical implications.

M. Hilleman, 2001, Vaccine.

The dilemma of AIDS vaccine and therapy. Possible clues from comparative pathogenesis with measles.

M. Hilleman, 1992, AIDS research and human retroviruses.

Immunological Studies on the Psittacosis-lymphogranuloma Group of Viral Agents

M. Hilleman, 1945 .

Stabilized measles vaccine in a novel single-dose delivery system: a practical reality for worldwide elimination of measles.

M. Hilleman, H. Markus, A. Mclean, 1983, Reviews of infectious diseases.

Poly I:C/poly-L-lysine: potent inducer of interferons in primates.

M. Hilleman, A. Field, A. Tytell, 1981, Journal of interferon research.

The indirect complement fixation hemagglutination and conglutinating complement absorption tests for viruses of the psittacosis-lymphogranuloma venereum group.

M. Hilleman, D. Haig, R. J. Helmold, 1951, Journal of immunology.

Seroepidemiologic Investigations of Human Hepatitis Caused by A, B, and a Possible Third Virus 1

M. Hilleman, A. Mclean, P. Provost, 1976, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Development and utilization of complement-fixation and immune adherence tests for human hepatitis A virus and antibody.

M. Hilleman, W. Miller, W. Mcaleer, 1975, American Journal of the Medical Sciences.

Group-specificity of psittacosis-lymphogranuloma venereum group skin test antigens in lymphogranuloma venereum patients.

A. B. Greaves, M. Hilleman, J. Werner, 1958, The Journal of laboratory and clinical medicine.

In vivo and in vitro studies of serological specificity among viruses of the psittacosis-lymphogranuloma venereum group.

M. Hilleman, D. Haig, R. J. Helmold, 1952, Journal of Immunology.

On Use of Urea- and Phenol-Treated Skin Test Antigens for Diagnosis of Lymphogranuloma venereum.

M. Hilleman, A. Grace, Clara Xigg, 1947, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Studies on lymphogranuloma venereum complement-fixing antigens; fractionation with organic solvents of antigens of the psittacosis-lymphogranuloma venereum group.

M. Hilleman, C. Nigg, 1947, Journal of immunology.

Studies on lymphogranuloma venereum complement-fixing antigens the solubility in ether of an active fraction.

M. Hilleman, C. Nigg, 1946, Journal of immunology.

A PROTECTIVE ANTISERUM AGAINST MOUSE PNEUMONITIS VIRUS.

M. Hilleman, F. B. Gordon, 1943, Science.

Part II. Mechanism of DNA Uptake and Antigen Presentation: Fate and Function of Foreign Nucleic Acids Use of Plasmid DNA for Direct Gene Transfer and Immunization.

M. Hilleman, R. Kurth, Margaret A. Liu, 1995 .

Lack of identity of polyoma virus and pneumonia virus of mice (PVM).

M. Hilleman, A. Girardi, 1960, Virology.

A Field Trial of Combined Measles- Mumps-Rubella Vaccine

M. Hilleman, G. Solari, J. Borgoño, 1973, Clinical pediatrics.

Live attenuated mumps virus vaccine. II. Early clinical studies.

M. Hilleman, R. Weibel, J. Stokes, 1967, Pediatrics.

Discovery of simian virus 40 (SV40) and its relationship to poliomyelitis virus vaccines.

M. Hilleman, M R Hilleman, Maurice R. Hilleman, 1998, Developments in biological standardization.

Production of purified hepatitis B surface antigen from Alexander hepatoma cells grown in artificial capillary units.

F. J. Bailey, M. Hilleman, P. Keller, 1983, Journal of virological methods.

Comparison of the antigenic patterns of influenza A virus strains determined by in ovo neutralization and hemagglutination-inhibition.

M. Hilleman, F. Horsfall, 1952, Journal of immunology.

Recombinant yeast hepatitis B vaccine.

M. Hilleman, 1986, Developments in biological standardization.

New Antigenic Variant in Far East Influenza Epidemic, 1957

I. Crawford, M. Hilleman, H. M. Meyer, 1957, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

New metabolizable immunologic adjuvant for human use. IX. Large-scale trials with multiple lots in different regimens.

M. Hilleman, R. Weibel, A. Woodhour, 1969, JAMA.

New Metabolizable Immunologic Adjuvant∗ for Human Use. I. Development and Animal Immune Response

M. Hilleman, A. Woodhour, A. Tytell, 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

New metabolizable immunologic adjuvant for human use. X. Long-term serologic and clinical follow-up.

M. Hilleman, A. Friedman, R. Weibel, 1970, The American journal of medicine.

Influenza B in the Spring of 1965

M. Hilleman, M. B. Leagus, C. Mascoli, 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Respiratory virus vaccines. V. Field evaluation for efficacy of heptavalent vaccine.

M. Hilleman, R. Weibel, J. Stokes, 1966, The American review of respiratory disease.

New metabolizable immunologic adjuvant for human use. 5. Evaluation of highly purified influenza-virus vaccine in adjuvant 65.

M. Hilleman, R. Weibel, A. Woodhour, 1967, The New England journal of medicine.

The Induction of Interferon

M. Hilleman, A. Tytell, 1971 .

Herpes simplex vaccines.

M. Hilleman, 1976, Cancer Research.

Virus vaccines

M. Hilleman, 1985, Nature.

Overview of the Needs and Realities for Developing New and Improved Vaccines in the 21st Century

M. Hilleman, 2003, Intervirology.

Respiratory virus vaccines. VII. Field evaluation of respiratory syncytial, parainfluenza 1, 2, 3, and Mycoplasma pneumoniae vaccines, 1965 to 1966.

M. Hilleman, P. Vella, R. Weibel, 1967, The American review of respiratory disease.

Feline leukemia virus envelope glycoprotein vaccine: preparation and evaluation of immunizing potency in guinea pig and cat.

M. Hilleman, R. Salerno, E. Lehman, 1978, Journal of the National Cancer Institute.

Inducers of Interferon and Host Resistance VI. Antiviral Efficacy of Poly I:C in Animal Models

M. Hilleman, A. Field, A. Tytell, 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Influence of Synthetic (Poly I:C) and Viral Double-Stranded Ribonucleic Acids on Adenovirus 12 Oncogenesis in Hamsters∗

M. Hilleman, W. Clark, V. Larson, 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Studies for safety of adjuvant 65.

M. Hilleman, A. Friedman, A. Woodhour, 1972, Annals of allergy.

Replacement of animal serum proteins by human albumin for growth and interferon production by Namalva cells

M. Hilleman, A. Field, A. Tytell, 1980, Antimicrobial Agents and Chemotherapy.

Whether and when an AIDS vaccine?

M. Hilleman, 1995, Nature Medicine.

Respiratory viruses and respiratory virus vaccines.

M. Hilleman, 1963, The American review of respiratory disease.

Vaccine Supply and Innovation

M. Hilleman, 1987 .

Clinical and Laboratory Studies of Live Attenuated RA 27/3 and HPV 77-DE Rubella Virus Vaccines

M. Hilleman, A. Mclean, R. Weibel, 1980, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

New Metabolizable Immunologic Adjuvant∗ for Human Use 8. Chronic Toxicity and Teratogenic Tests

M. Hilleman, A. Woodhour, H. Peck, 1968, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Live Respiratory Syncytial Virus Vaccine Administered Parenterally

M. Hilleman, A. Mclean, R. Weibel, 1978, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Past, present, and future of measles, mumps, and rubella virus vaccines.

M. Hilleman, 1992, Pediatrics.

Development of Immunity Against Hepatitis A Virus by Subclinical Infection 1

M. Hilleman, P. Provost, V. Villarejos, 1976, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Progress toward a live attenuated human hepatitis A virus vaccine.

M. Hilleman, A. Mclean, E. Buynak, 1983, Developments in biological standardization.

Isolation of Hepatitis A Virus in Vitro in Cell Culture Directly from Human Specimens

M. Hilleman, W. Mcaleer, P. Provost, 1981, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Physical, chemical and morphologic dimensions of human hepatitis A virus strain CR326 (38578).

M. Hilleman, W. Miller, W. Mcaleer, 1975, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Therapeutic vaccines: Realities of today and hopes for tomorrow

M. Hilleman, M. Sela, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Prevention of SV40 Virus Tumorigenesis in Newborn Hamsters by Maternal Immunization.∗ †

M. Hilleman, V. Larson, W. G. Raupp, 1967 .

Respiratory virus vaccines. II. Mycoplasma pneumoniae (Eaton agent) vaccines.

M. Hilleman, P. Vella, R. Weibel, 1966, American Review of Respiratory Disease.

Ten-Year Follow-Up Study for Safety of Adjuvant 65 Influenza Vaccine in Man

M. Hilleman, A. Friedman, A. Mclean, 1973, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Failure of Thymopoietin, Ubiquitin and Synthetic Serum Thymic Factor to Restore Immunocompetence in T-Cell Deficient Mice

M. Hilleman, H. Schwam, D. Martinez, 1978, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Inducers of Interferon and Host Resistance VII. Antiviral Efficacy of Double-Stranded RNA of Natural Origin

M. Hilleman, A. Field, A. Tytell, 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Differentiation of Virulent from Avirulent Measles Strains

M. Hilleman, E. Buynak, H. Goldner, 1962 .

Respiratory virus vaccines. 8. Field evaluation of trivalent parainfluenza virus vaccine among preschool children in families, 1967-1968.

M. Hilleman, P. Vella, R. Weibel, 1969, The American review of respiratory disease.

Development of a purified poliomyelitis virus vaccine.

M. Hilleman, A. Tytell, J. Charney, 1961, JAMA.

Field evaluation of combined more attenuated live measles (Moraten)-smallpox vaccine in Honduras and Costa Rica.

M. Hilleman, E. Buynak, V. Villarejos, 1971, American journal of epidemiology.

Clinical laboratory experiences with a more attenuated Enders' measles virus vaccine (Moraten) combined with smallpox vaccine.

M. Hilleman, R. Weibel, J. Stokes, 1969, Pediatrics.